Consumer Discretionary • Specialty Chemicals
$153.73 ▼ -0.33
(-0.21%)
MKT CAP: $3.20B • VOL: 103.6K
52W L $116 52W H $174
CONSENSUS RATING DISTRIBUTION (40 DESKS)
BUY: 30 HOLD: 8
SELL: 2
12M STREET TARGET RANGE
IMPLIED: +14.0%
LOW
$129
MEDIAN
$172
MEAN
$175
HIGH
$209
STREET BS CREDIBILITY SCORE 1Y BACKTESTED
68/100
EMPIRICAL HIT RATE VS SPOT
GRADES WHETHER SELL-SIDE TARGET REVISIONS LEAD OR CHASE HWKN TAPE
HWKN // FIRM-BY-FIRM ANALYST BACKTEST & BS DETECTOR (ANR <GO>)
CURRENT 90D STREET CONSENSUS
| INSTITUTION / ANALYST | ACTION | RATING | TARGET | PRIOR PT | CALL DATE | PX AT CALL | RET SINCE CALL | 1Y ACCURACY | BS GRADE |
|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley Institutional Equity Desk | REITERATE | OUTPERFORM | $186.01 | $176.79 | 2025-02-14 | $139.89 | +9.9% | 78% | A |
| Goldman Sachs Global Research Sector Coverage | TARGET REV | STRONG BUY | $193.70 | $181.40 | 2025-02-06 | $144.51 | +6.4% | 74% | A |
| J.P. Morgan Securities US Large Cap | REITERATE | BUY | $175.25 | $169.10 | 2025-01-29 | $147.58 | +4.2% | 67% | B |
| Bernstein Autonomous Forensic Coverage | INITIATE | HOLD | $156.80 | — | 2025-01-17 | $150.66 | +2.0% | 61% | B |
| Barclays Capital Americas Research | DOWNGRADE | UNDERPERFORM | $135.28 | $146.04 | 2025-01-09 | $136.82 | -11.2% | 42% | D |
| UBS Investment Bank Institutional Desk | UPGRADE | BUY | $182.94 | $159.88 | 2024-12-18 | $133.75 | +14.9% | 72% | A |
| Citigroup Global Markets Sector Lead | TARGET REV | HOLD | $149.12 | $155.27 | 2024-12-04 | $142.97 | -4.3% | 48% | C |